相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Palmoplantar pustulosis should not be considered as a variant of psoriasis
A. Ammoury et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management
E. Papadavid et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Pustular psoriasis induced by infliximab
C. Martinez-Moran et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Another paradox in Crohn's disease:: New onset of psoriasis in a patient receiving tumor necrosis factor-α antagonist
Erika Angelucci et al.
INFLAMMATORY BOWEL DISEASES (2007)
Psoriasiform and pustular eruption induced by infliximab
Hidetoshi Takahashi et al.
JOURNAL OF DERMATOLOGY (2007)
Efalizumab-associated papular psoriasis
Akmal S. Hassan et al.
ARCHIVES OF DERMATOLOGY (2007)
Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers
R. Goiriz et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists
H-H. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Eruptive papules during efalizumab (anti-CD I Ia) therapy of psoriasis vulgaris: a case series
Michelle A. Lowes et al.
BMC DERMATOLOGY (2007)
Onset of psoriasis during treatment with TNF-α antagonists:: A report of 3 cases
Ravi Ubriani et al.
ARCHIVES OF DERMATOLOGY (2007)
Occurrence of psoriasis in a patient presenting Shulman fasciitis treated with infliximab
A. Cavailhes et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2007)
Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease
Junji Umeno et al.
INFLAMMATORY BOWEL DISEASES (2007)
The appearance of pustular psoriasis during antitumor necrosis factor therapy
Deborah Pereira Goncalves et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Anti-TNF-α-induced psoriasis:: Case report of an unusual adverse event
Spyros Aslanidis et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations
A. Massara et al.
RHEUMATOLOGY (2006)
The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking
G Michaëlsson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists
S Kary et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Newer therapeutic approaches: Spondyloarthritis and uveitis
C Ritchlin
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2006)
Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: Three further cases and current overview
D. Pirard et al.
DERMATOLOGY (2006)
Infliximab can precipitate as well as worsen palmoplantar pustulosis:: possible linkage to the expression of tumour necrosis factor-α in the normal palmar eccrine sweat duct?
G Michaëlsson et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Impact of obesity and smoking on psoriasis presentation and management
MD Herron et al.
ARCHIVES OF DERMATOLOGY (2005)
Onset of flexural psoriasis during infliximab treatment for Crohn's disease
L Peramiquel et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2005)
Increased sensitivity to interferon-a in psoriatic T cells
KW Eriksen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Pustular skin lesions in patients treated with infliximab: report of two cases
MJF Starmans-Kool et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Psoriasis induced by anti-tumor necrosis factor therapy - A paradoxical adverse reaction
PP Sfikakis et al.
ARTHRITIS AND RHEUMATISM (2005)
Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept?
S Ehlers
CLINICAL INFECTIOUS DISEASES (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al
B Grinblat et al.
ARTHRITIS AND RHEUMATISM (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of biological agents inflammatory diseases
P Efthimiou et al.
SOUTHERN MEDICAL JOURNAL (2005)
Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-α inhibitors
D Aeberli et al.
RHEUMATOLOGY (2005)
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease
PP Sfikakis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Psoriatic lesions induced by antitumour necrosis factor-α treatment:: two cases
O Dereure et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
M Gilliet et al.
ARCHIVES OF DERMATOLOGY (2004)
Psoriasiform eruption induced by infliximab
MM Verea et al.
ANNALS OF PHARMACOTHERAPY (2004)
In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered
L Van der Fits et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
A randomized trial of etanercept as monotherapy for psoriasis
AB Gottlieb et al.
ARCHIVES OF DERMATOLOGY (2003)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
D Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Tumor necrosis factor biology in experimental and clinical arthritis
PP Sfikakis et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas
W Vermi et al.
JOURNAL OF PATHOLOGY (2003)
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis
AB Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Clinical research helps elucidate the role of tumor necrosis factor-alpha in the pathogenesis of T-1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes
AB Gottlieb
LUPUS (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α
JD Gorman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial
J Braun et al.
LANCET (2002)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling
S Hida et al.
IMMUNITY (2000)
Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis
H Niizeki et al.
TISSUE ANTIGENS (2000)
Skin nerve fibres and their contacts with mast cells in patients with palmoplantar pustulosis
E Hagforsen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2000)
Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
CJ Oh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Autoimmune diseases: A leading cause of death among young and middle-aged women in the United States
SJ Walsh et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
分享论文
